The behavioural and psychological impact of genetic testing for lung cancer susceptibility was examined among smokers (N = 61) who were randomly allocated to a GSTM1 genetic testing group (with GSTM1-missing or GSTM1-present result) or no-test control group. The GSTM1-missing (higher risk) group reported greater motivation to quit smoking, and both genetic testing groups reported lower depression than the control group at one-week follow-up (p < .05 for all). Differences were not significant at two months follow-up. This study indicates the feasibility of much-needed research into the risks and benefits for individuals of emerging lifestyle-related genetic susceptibility tests.
Audrain, J., Boyd, N.R., Roth, J., Main, D., Caporaso, N.F., & Lerman, C. (1997). Genetic susceptibility testing in smoking-cessation treatment: One-year outcomes of a randomized trial. Addictive Behaviors, 22, 741-751.
2.
Benhamou, S., Lee, W.J., Alexandrie, A.K., Boffetta, P., Bouchardy, C., Butkiewicz, D. et al. (2002). Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk . Carcinogenesis, 23, 1343-1350.
3.
Braithwaite, D., Sutton, S., & Steggles, N. (2002). Intention to participate in predictive genetic testing for hereditary cancer: The role of attitude toward uncertainty. Psychology and Health, 17, 761-772.
4.
Burke, W., Atkins, D., Gwinn, M., Guttmacher, A., Haddow, J., Lau, J. et al. (2002). Genetic test evaluation: Information needs of clinicians, policy makers, and the public. American Journal of Epidemiology, 156, 311-318.
5.
Campbell, M., Fitzpatrick, R., Haines, A., Kinmonth, A.L., Sandercock, P., Spiegelhalter, D. et al. (2000). Framework for design and evaluation of complex interventions to improve health. British Medical Journal , 321, 694-696.
6.
Casas, J.P., Cooper, J., Miller, G.J., Hingorani, A.D., & Humphries, S.E. (2006). Investigating the genetic determinants of cardiovascular disease using candidate genes and meta-analysis of association studies. Annals of Human Genetics, 70, 145-169.
7.
Collins, F.S., Green, E.D., Guttmacher, A.E., & Guyer, M.S. (2003). A vision for the future of genomics research. Nature, 422, 835-847.
8.
Esplen, M.J., Madlensky, L., Butler, K., McKinnon, W., Bapat, B., Wong, J. et al. (2001). Motivations and psychosocial impact of genetic testing for HNPCC. American Journal of Medical Genetics , 103, 9-15.
9.
Evers-Kiebooms, G., Welkenhuysen, M., Claes, E., Decruyenaere, M., & Denayer, L. (2000). The psychological complexity of predictive testing for late onset neuro-genetic diseases and hereditary cancers: Implications for multidisciplinary counselling and for genetic education. Social Science and Medicine, 51, 831-841.
Frosch, D.L., Mello, P., & Lerman, C. (2005). Behavioral consequences of testing for obesity risk. Cancer Epidemiology, Biomarkers and Prevention, 14, 1485-1489.
12.
Haga, S.B., Khoury, M.J., & Burke, W. (2003). Genomic profiling to promote a healthy lifestyle: Not ready for prime time. Nature Genetics, 34, 347-350.
13.
Heatherton, T.F., Kozlowski, L.T., Frecker, R.C., & Fagerstrom, K.O. (1991). The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire . British Journal of Addiction, 86, 1119-1127.
14.
Holtzman, N.A., Murphy, P.D., Watson, M.S., & Barr, P.A. (1997). Predictive genetic testing: From basic research to clinical practice. Science, 278, 602-605.
15.
Houlston, R.S. (1999). Glutatione S-transferase M1 status and lung cancer risk: A meta-analysis. Cancer Epidemiology, Biomarkers and Prevention, 8, 675-682.
16.
Lader, D., & Goddard, E. (2002). Smoking related behaviour and attitudes, 2001. London: Office for National Statistics.
17.
Lancaster, T., & Stead, L.F. (2005). Self-help interventions for smoking cessation . Cochrane Database of Systematic Reviews, CD001118.
18.
Lerman, C., Gold, K., Audrain, J., Lin, T.H., Boyd, N.R., Orleans, C.T. et al. (1997). Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: Effects on smoking-related cognitions, emotions, and behavior change. Health Psychology , 16, 87-99.
19.
Lerman, C., Hughes, C., Lemon, S.J., Main, D., Snyder, C., Durham, C. et al. (1998). What you don't know can hurt you: Adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. Journal of Clinical Oncology, 16, 1650-1654.
20.
Li, L.C., Yeh, C.C., Nojima, D., & Dahiya, R. (2000). Cloning and characterization of human estrogen receptor beta promoter. Biochemistry and Biophysics Research Communications, 275, 682-689.
21.
Lipkus, I.M., McBride, C.M., Pollak, K.I., Lyna, P., & Bepler, G. (2004). Interpretation of genetic risk feedback among African American smokers with low socioeconomic status. Health Psychology, 23, 178-188.
22.
Malamud, D., & Tabak, L. (1993). Guidelines for saliva nomenclature and collection: Saliva as a diagnostic fluid. Annals of the NY Academy of Science, 694, xi-xii.
23.
McBride, C.M., Bepler, G., Lipkus, I.M., Lyna, P., Samsa, G., Albright, J. et al. (2002). Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income . Cancer Epidemiology, Biomarkers and Prevention, 11, 521-528.
24.
McBride, C.M., Halabi, S., Bepler, G., Lyna, P., McIntyre, L., Lipkus, I. et al. (2000). Maximizing the motivational impact of feedback of lung cancer susceptibility on smokers' desire to quit. Journal of Health Communication, 5, 229-241.
25.
McBride, C.M., Lipkus, I.M., Jolly, D., & Lyna, P. (2005). Interest in testing for genetic susceptibility to lung cancer among Black college students 'at risk' of becoming cigarette smokers. Cancer Epidemiology, Biomarkers and Prevention, 14, 2978-2981.
26.
McWilliams, J.E., Sanderson, B.J., Harris, E.L., Richert-Boe, K.E., & Henner, W.D. (1995). Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiology, Biomarkers and Prevention, 4, 589-594.
27.
Meiser, B., & Dunn, S. (2000). Psychological impact of genetic testing for Huntington's disease: An update of the literature. Journal of Neurology, Neurosurgery and Psychiatry, 69, 574-578.
28.
Moss-Morris, R., Weinman, J., Petrie, K.J., Horne, R., Cameron, L.D., & Buick, D. (2002). The Revised Illness Perception Questionnaire (IPQ-R) . Psychology and Health, 17, 1-16.
29.
Sanderson, S.C., & Wardle, J. (2005). Will genetic testing for complex diseases increase motivation to quit smoking? Anticipated reactions in a survey of smokers. Health Education and Behavior, 32, 640-653.
30.
Sanderson, S., Zimmern, R., Kroese, M., Higgins, J., Patch, C., & Emery, J. (2005). How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom. Genetics in Medicine, 7, 495-500.
31.
Stead, L.F., Perera, R., & Lancaster, T. (2006). Telephone counselling for smoking cessation. Cochrane Database of Systematic Reviews, 3, CD002850.
32.
Sutton, S., Bickler, G., Sancho-Aldridge, J., & Saidi, G. (1994). Prospective study of predictors of attendance for breast screening in inner London. Journal of Epidemiology and Community Health, 48, 65-73.
33.
Vickers, A.J., & Altman, D.G. (2001). Statistics notes: Analysing controlled trials with baseline and follow up measurements. British Medical Journal, 323, 1123-1124.
34.
Weinman, J., Petrie, K., Moss-Morris, R., & Horne, R. (1996). The illness perception questionnaire: A new method for assessing the cognitive representation of illness. Psychology and Health, 11, 114-129.
35.
Wiggins, S., Whyte, P., Huggins, M., Adam, S., Theilmann, J., Bloch, M. et al. (1992). The psychological consequences of predictive testing for Huntington's disease: Canadian Collaborative Study of Predictive Testing. New England Journal of Medicine, 327, 1401-1405.
36.
Witte, K. (1992). Putting the fear back into fear appeals: The Extended Parallel Process Model. Communication Monographs, 59, 329-349.
37.
Witte, K., McKeon , J., Cameron, K., & Berkowitz, J. (1995). The Risk Behavior Diagnosis Scale: A health educator's tool. East Lansing, MI: Michigan State University.
38.
Wright, A.J., Weinman, J., & Marteau, T.M. (2003). The impact of learning of a genetic predisposition to nicotine dependence: An analogue study. Tobacco Control , 12, 227-230.
39.
Yang, Q., Khoury, M.J., Friedman, J., Little, J., & Flanders, W.D. (2005). How many genes underlie the occurrence of common complex diseases in the population? International Journal of Epidemiology, 34, 1129-1137.
40.
Zigmond, A.S., & Snaith, R.P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavia, 67, 361-370.
